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We used an antibody raised against a synthetic peptide corresponding to amino acid residues 70–88 for characterizing the
L* protein of Theiler’s murine encephalomyelitis virus (TMEV), which is only synthesized in DA subgroup strains from an
alternative AUG and is out of frame with the viral polyprotein; evidence suggests that L* protein is critical to viral persistence,
demyelination, and growth in murine macrophage cell lines. It was synthesized with kinetics similar to that of other viral
proteins, although less in amount. After synthesis, it remained stable in the cytoplasm and was not incorporated into virions.
Immunofluorescent staining and immunoblotting of microtubule preparations demonstrated that it is associated with
microtubules. Expression of L* protein also demonstrated that the 59 one third of the coding region may be responsible for
the association. The association of L* protein with microtubules may be important in the disease-inducing and in vitro
characters of L* protein. © 2001 Academic Press
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vINTRODUCTION
Theiler’s murine encephalomyelitis virus (TMEV), a
member of the genus Cardiovirus, includes a number of
strains that are divided into two subgroups on the basis
of their different in vivo activities (reviewed in Lipton and
Jelachich, 1997; Obuchi and Ohara, 1998). GDVII sub-
group strains cause acute polioencephalomyelitis in
mice with neither virus persistence nor demyelination. In
contrast, DA or TO subgroup strains induce an early
nonfatal polioencephalomyelitis of weanling mice fol-
lowed by chronic demyelination with virus persistence.
This late demyelinating disease serves as an experimen-
tal model of a human demyelinating disease, multiple
sclerosis, because both diseases have a similar inflam-
matory white matter pathology. Although the molecular
basis for the different biological activities among those
two subgroups is still unclear, DA subgroup strains of
TMEV synthesize a 17-kDa protein, called L*, which is
out of frame with the viral polyprotein and therefore
translated independently from an alternative AUG, 13
nucleotides (nt) downstream from the polyprotein’s AUG
(Kong and Roos, 1991; Roos et al., 1989). On the other
hand, GDVII subgroup strains have an ACG correspond-
ing in location to the L* protein initiation codon (Michiels
et al., 1995) and fail to synthesize L* protein. Several
studies have demonstrated that L* protein is multifunc-
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95tional and important for viral persistence and demyelina-
tion (Chen et al., 1995; Ghadge et al., 1998; Lin et al.,
1999; Obuchi et al., 1999, 2000; Takata et al., 1998). The
detailed characterization of L* protein has been ham-
pered, however, because of the lack of a specific anti-
body against L* protein. In the present study, we gener-
ated anti-L* antibody and used this reagent to charac-
terize L* protein. Although L* protein is reported to play
an important role in macrophage cell lines (Obuchi et al.,
1999, 2000; Takata et al., 1998), most of the experiments
were performed using baby hamster kidney (BHK)-21
cells, which are permissive for TMEV and produce a fair
amount of L* protein, enough for characterization.
RESULTS
Specificity of polyclonal antibody against L* protein
To examine whether the antipeptide antibodies spe-
cifically detected the L* protein, virus-infected BHK-21
cells were harvested at 20 h postinoculation (p.i.) and
examined by Western blotting. Antiserum from a rabbit
immunized with the peptide corresponding to amino
acid residues 70–88 detected a distinct 17-kDa band
(Fig. 1, lane 1). In contrast, sera from rabbits immu-
nized against amino acid residues 118–136 and 139–
156 failed to react with the 17-kDa band (Fig. 1, lanes
2 and 3). The antibody against amino acid residues
70–88, designated aL*, did not react against any other
iral proteins and had very minimal reaction with any
ellular proteins (Fig. 1, lane 4), indicating that it is
ighly specific for L* protein.
0042-6822/01 $35.00
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96 OBUCHI ET AL.Kinetics of L* protein synthesis
We next examined the kinetics of L* protein synthesis
in BHK-21 cells during the viral infection cycle by Western
blotting using the aL* antibody. As shown in Fig. 2A, L*
rotein was first detected 4 h p.i., increased rapidly in
mount by 6 h p.i., peaked, and plateaued at 10 h p.i. in
rder to compare the kinetics of L* protein with that of
ther viral proteins which are translated from the
olyprotein AUG, DA strain-infected BHK-21 cells were
ulse-labeled for 2 h at 0, 2, 4, 6, 8, and 10 h p.i.,
espectively, with a mixture of [35S]methionine and
[35S]cysteine and the radiolabeled proteins were ana-
yzed by sodium dodecyl sulfate (SDS)–polyacrylamide
el electrophoresis (PAGE). The viral capsid proteins
ere synthesized from 4 to 12 h p.i. with similar kinetics
o that of L* protein (Fig. 2B). The amount of L* protein
ynthesized, however, was far less than that of those
apsid proteins.
* protein is stable and not incorporated into virions
We next examined the stability of L* protein after
ynthesis in the cytoplasm by the pulse–chase experi-
ent. Virus-infected cells were radiolabeled for 10 min
nd chased for 1 and 3 h. There was no change in the
obility and signal intensity of L* protein (Fig. 3A). For
FIG. 1. Specificity of anti-L* antibody. DA-infected (lanes 1–3) and
mock-infected (lane 4) cells were electrophoresed and analyzed by
Western blotting using rabbit polyclonal antibodies raised to three
peptides, which corresponds to the computer-predicted antigenic sites
(amino acid residues 70–88, 118–136, and 139–156). Only the antibody
raised to the peptide corresponding to amino acid residues 70–88 (aL*)
eacted with the 17-kDa molecule. Lanes 1 and 4, antibody raised to
eptide corresponding to amino acid residues 70–88; lane 2, amino
cid residues 118–136; lane 3, amino acid residues 139–156.urther confirmation, the chase time was lengthened to
h; the mobility and signal intensity did not change evenn the 9 h-chase (Fig. 3B). Therefore, the data suggested
hat L* protein was stable after synthesis in infected
ells. In order to examine whether L* protein is incorpo-
ated into virions, purified virions of the DA strain were
ext tested by Western blotting using a mixture of aL*
antibody and monoclonal antibody against VP1, DAmAb2
(Nitayaphan et al., 1985), as the first antibodies. The
minimum amount of synthetic peptide corresponding to
amino acid residues 70–88 which could be detected by
Western blotting was 2 ng (data not shown), which cor-
responded to 5.6 3 1011 molecules of L* protein and 7.9
mg of purified virus (Rueckert, 1996) (assuming one mol-
ecule of L* protein was incorporated into one viral par-
ticle). As shown in the Western blotting, no L* protein
was detected in 24 mg of purified virus (more than 3
times the detection threshold) (Fig. 4, lane 1) although
both VP1 and L* proteins were clearly demonstrated in
the lysate of DA-infected BHK-21 cells (Fig. 4, lane 2).
Although the band corresponding to 30 kDa was ob-
served (Fig. 4, lane 1), the preliminary experiment
showed that DAmAb2 reacted nonspecifically and that
the band was not a modified form of L* protein (data not
FIG. 2. Synthesis of L* and other viral proteins in DA-infected BHK-21
cells. (A) BHK-21 cells were infected at an m.o.i. of 10 PFU per cell.
Unlabeled electrophoresed proteins were analyzed by Western blotting
with aL* antibody and horseradish peroxidase-conjugated anti-rabbit
IgG as the first and second antibodies, respectively. (B) Synthesized
proteins radiolabeled as described in the text were analyzed by SDS–
15% PAGE. L* protein was first detected 4 h p.i., rapidly increased to 6 h
p.i., and plateaued at 10 h p.i. The kinetics of other viral protein
synthesis were correlated with that of L* protein. The number at the top
of each panel indicates hour(s) p.i. Lane M is mock-infected BHK-21
cells.
c
i
n
n
f
s
o
T
97ASSOCIATION OF L* PROTEIN OF TMEV WITH MICROTUBULESshown). The result indicated that L* protein was not
incorporated into virions.
Localization of L* protein in infected cells
Finally, we examined the intracellular localization of L*
protein by indirect immunofluorescence using aL* anti-
body. At 4 h p.i., the signal of L* protein was first detected
in infected cytoplasm as a filamentous fluorescent signal
(Fig. 5Ac). The signal increased in intensity over time and
became somewhat punctated at 5 h p.i. (Fig. 5Ae). At 6 h
p.i., along with the appearance of cytopathic effects, L*
was polarized in distribution in the cytoplasm (Fig. 5Ag).
Because this distribution resembled that of the cytoskel-
eton, we performed double fluorescent studies with anti-
b-tubulin antibody. The studies showed that the distribu-
tion of L* coincided with that of b-tubulin (Figs. 5Ad, 5Af,
and 5Ah). The merging image of L* and b-tubulin signals
also demonstrated the coincidence of L*/b-tubulin sig-
nals (Fig. 5Ba). However, the signal of L* diverged from
that of actin or vimentin (Figs. 5Bb and 5Bc). In order to
further explore a domain responsible for the association
of L* with microtubules, the L* coding sequence was
divided into three portions, i.e., 59, middle, and 39 por-
tions. The whole sequence and the sequence of each
portion were cloned into a cloning vector (pCMV-TagL*,
pCMV-TagL*N, pCMV-TagL*M, and pCMV-TagL*C, re-
spectively) and were transiently expressed in BHK-21
FIG. 3. Stability of L* protein. DA-infected BHK-21 cells were labeled
at 9 h p.i. for 10 or 60 min as described in the text, subsequently
washed three times in Eagle’s MEM supplemented with 0.15 mg of
methionine/ml and 0.31 mg of cysteine/ml, and chased for 1, 3, or 9 h
in Eagle’s MEM supplemented with the same concentrations of methi-
onine and cysteine. No change in the mobility and signal intensity of L*
protein was observed during the chase time. (A) Pulse-labeled for 10
min, (B) pulse-labeled for 60 min. The number at the top of each panel
indicates hour(s) of chase time.cells. For detection of the expressed L* protein or the
expressed truncated L* proteins, anti-FLAG antibodywas used because aL* does not detect all of the trun-
ated L* proteins. As shown in Fig. 6a, the merging
mage of the whole L* (pCMV-TagL*) and b-tubulin sig-
als demonstrated the coincidence of L*/b-tubulin sig-
als as observed in infected cells. Almost the same
eature was observed in the case of the 59 one-third
equence (pCMV-TagL*N) (Fig. 6b). However, the signal
f the middle or the 39 one-third sequence (pCMV-
agL*M or pCMV-TagL*C) diverged from that of b-tubulin
(Figs. 6c and 6d).
The immunofluorescent studies suggested that L* pro-
tein is associated with microtubules. To further confirm
the association of L* protein with microtubules, a micro-
tubule fraction was isolated from DA-, DAL*-1-, and
mock-infected BHK-21 cells using paclitaxel, which in-
hibits the disassembly of microtubules. DAL*-1 virus has
an ACG rather than AUG at the starting codon of the L*
coding region, therefore synthesizing no L* protein (Kong
and Roos, 1991). The fraction that contained microtu-
bules also contained L* protein in the case of the DA
strain (Fig. 7A, lane 1). No L* protein signal was, how-
ever, detected in the fractions from DAL*-1- and mock-
infected BHK-21 cells (Fig. 7A, lanes 2 and 3). For com-
parison with other viral protein(s), Western blotting using
DAmAb2 was also performed. The fractions that con-
tained microtubules did not contain VP1, indicating that
microtubules are associated with L* protein in infected
FIG. 4. Failure of detection of L* protein in DA virions. Incorporation
of L* protein into virions was analyzed by Western blotting with a
mixture of aL* antibody and a monoclonal antibody against VP1 of
TMEV as the first antibody. Although both VP1 and L* proteins were
clearly observed in the lysate of DA-infected BHK-21 cells (lane 2), no
L* protein was detected in purified virions (lane 1). Lane 1, purified
virions; lane 2, DA-infected BHK-21 cells; lane M, mock-infected BHK-21
cells.
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98 OBUCHI ET AL.cells but not with viral capsid protein. As several studies
reported that the function of L* protein for virus growth is
observed in macrophage cell lines (Obuchi et al., 1999,
000; Takata et al., 1998; van Eyll and Michiels, 2000), the
ssociation of L* protein with microtubules was exam-
ned in a murine macrophage-like cell line, J774-1, as
ell. As shown in Fig. 7B, the microtubule fraction con-
FIG. 5. Distribution of L* protein in DA-infected BHK-21 cells. (A)
BHK-21 cells were infected with the DA strain at an m.o.i. of 10 PFU per
cell. Cells were then fixed in 4% paraformaldehyde and permeabilized
with 0.2% Triton X-100. Cells were stained with aL* and FITC-conju-
gated goat anti-rabbit IgG antibodies. For L*/tubulin double staining,
the cells were further incubated with Cy3-conjugated anti-b-tubulin
onoclonal antibody. (B) The merging images of L*/b-tubulin, L*/actin,
and L*/vimentin signals. The 5-h p.i. image of L* protein was merged
with that of b-tubulin, actin, or vimentin. Throughout the infection, the
signal of L* protein was coincident with that of b-tubulin, although the
signal of L* protein was divergent from that of actin or vimentin. (Aa, c,
e, g) L* protein detected with aL* antibody; (Ab, d, f, h) microtubules
etected by anti-b-tubulin monoclonal antibody. The number at the left
of panel A indicates hour(s) p.i. (Ba) The merging image of L*/b-tubulin
5 h p.i.); (Bb) L*/actin (5 h p.i.); (Bc) L*/vimentin (5 h p.i.).ained L* protein, although L* protein was not detected in
he fraction from mock-infected J774-1 cells. The datandicated that L* protein was associated with microtu-
ules in both BHK-21- and J774-1-infected cells.
DISCUSSION
The RNA genome of picornaviruses is translated into a
ong viral polyprotein, followed by cleavage into viral
tructural and nonstructural proteins. In some non-TMEV
icornaviruses, there is an alternative initiation codon
ownstream from the polyprotein AUG (Kaminski et al.,
990; Sangar et al., 1987; Tesar et al., 1992). In these
cases, the alternative initiation codon is in frame with the
polyprotein, and a truncated polyprotein is synthesized in
addition to a full-length polyprotein. Uniquely in the case
of TMEV, the alternative AUG is used to synthesize a
17-kDa protein (L*), which is out of frame with the
polyprotein (Kong and Roos, 1991; Roos et al., 1989).
A number of functions are assigned to L* protein. L*
rotein appears important for virus persistence and de-
yelination (Chen et al., 1995; Ghadge et al., 1998). The
role of L* protein in virus persistence is presumably
related to its inhibition of the antivirus cytolytic T cell
activity that normally clears virus in the acute stage of
infection (Lin et al., 1999). L* protein also facilitates DA
subgroup-specific growth in monocyte or macrophage
cell lines (Obuchi et al., 1999, 2000; Takata et al., 1998;
van Eyll and Michiels, 2000). In addition, L* protein has
an antiapoptotic activity in these cells (Ghadge et al.,
1998). However, the role of L* protein is still under dis-
pute because a recent study by van Eyll and Michiels
(2000) reported that the presence or the absence of the
L* AUG initiation codon had only a weak influence on
viral persistence and demyelination. Therefore, the de-
tailed characterization of L* protein is essential for fur-
ther exploring its function.
There has been relatively little characterization of L*
protein. Chen et al. (1995) indirectly examined the local-
ization of an L*/hemagglutinin (HA) fusion protein by
using a monoclonal antibody against HA. Western blot-
ting demonstrated the presence of the fusion protein,
L*HA, in membrane fractions. However, analysis of L*
protein by specific antibody is essential to clearly ex-
plore the features of L* protein in TMEV infection. There-
fore, we generated antibody specifically directed to L*
protein. The antibody was successfully raised against
the relatively hydrophilic amino acid residues 70–88.
Western blotting showed that L* protein is not present
in virions. This is not unexpected since the GDVII strain
lacks L* protein but produces virions as well as the DA
strain in BHK-21 and other cells (Obuchi et al., 1997,
1999). L* protein is synthesized in parallel with other viral
proteins, although the amount is decreased. The num-
bers of methionine and cysteine residues in the L* cod-
ing region are 5 and 4, respectively. And those are almost
constant in capsid proteins (4 and 5 in VP1, 5 and 4 in
VP2, 6 and 6 in VP3). Ghadge et al. (1998) reported that
p
t gL*C d
L (d) pC
V
t
a
f
w
c
f
s
c
w
99ASSOCIATION OF L* PROTEIN OF TMEV WITH MICROTUBULESthe expression of L* protein varies in the different cell
types. Therefore, the amount of L* protein in the present
study may be due to the type of host cell or the condition
of culture. The pulse–chase experiments demonstrated
that L* protein was stable after synthesis. However, com-
puter analysis showed that L* protein has several puta-
tive modification motifs, i.e., casein kinase II phosphor-
ylation, protein kinase C phosphorylation, N-myristoyl-
ation, and N-glycosylation sites. Therefore, further
studies are required to examine whether L* protein un-
dergoes such posttranslational modifications.
FIG. 6. Transient expression of L* protein or the truncated L* protei
fragments corresponding to amino acid residues 1–52, 53–104, and 10
These fragments were cloned into pCMV-Tag2 and designated pCMV-Ta
cells were transfected with these constructs by the DEAE–dextran p
FITC-conjugated goat anti-rabbit IgG antibodies. For L*/tubulin double
monoclonal antibody. The figure shows the merging images of pCM
CMV-Tag L*C/b-tubulin signals. The coincidence of pCMV-Tag L*/b-tu
he case of pCMV-TagL*N, the signal of pCMV-TagL*M or pCMV-Ta
*/b-tubulin, (b) pCMV-Tag L*N/b-tubulin, (c) pCMV-Tag L*M/b-tubulin,
FIG. 7. Association of L* protein with microtubules. A microtubule
fraction was isolated from infected BHK-21 or J774-1 cells as described
in the text. The presence of a-tubulin, L* protein, and capsid protein
P1 in the fraction was examined by Western blotting using anti-a-
ubulin monoclonal antibody, aL* antibody, and DAmAb2 monoclonal
ntibody. (A) BHK-21 cells. The signal of L* protein was detected in the
raction extracted from DA-infected BHK-21 cells (lane 1), although it
as not detected in that from DAL*-1- (lane 2)- or mock-infected BHK-21
ells (lane 3). The signal of VP1 was not demonstrated in the fraction
rom DA-, DAL*-1-, or mock-infected cells. On the other hand, all the
ignals were clearly demonstrated in DA-infected cell lysate as a
ontrol (lane 4). (B) J774-1 cells. The signals of a-tubulin and L* protein
ere detected in infected J774-1 cells (lane 1), but only the signal of
a-tubulin was detected in the fraction extracted from mock-infected
J774-1 cells (lane 2). (A) Lane 1, DA-infected BHK-21 cells; lane 2,
DAL*-1-infected BHK-21 cells; lane 3, mock-infected BHK-21 cells; lanem
1
4, DA-infected BHK-21 cell lysate. (B) Lane 1, DA-infected J774-1 cells;
lane 2, mock-infected J774-1 cells.Ne´dellec et al. (1998) first demonstrated that DA and
GDVII virions bind specifically to intermediate filaments
(desmin and vimentin), a component of cytoskeleton. Our
data also demonstrated that L* protein, which is pro-
duced independently of the polyprotein only in DA sub-
group strains, has a similar distribution in infected cells
to microtubules, another component of the cytoskeleton.
These results are of interest since the cytoskeleton is
involved in the growth of a number of DNA and RNA
viruses (Bukrinskaya et al., 1998; Candurra et al., 1999;
Hill and Summers, 1990; Sodeik et al., 1997). In the case
of poliovirus and other picornaviruses, RNA associates
with the cytoskeleton during translation (Bonneau et al.,
1985; Lenk and Penman, 1979). The present study also
proposed the possibility that the 59 one third of L* protein
may be responsible for the association of L* with micro-
tubules. However, more precise localization of the do-
main remains to be defined. Microtubules contain vari-
ous other microtubular-associated proteins. It is another
issue of interest which protein is involved in the associ-
ation with L* protein. Our previous studies demonstrated
that L*-dependent TMEV growth in monocyte or macro-
phage cell lines is not related to adsorption of virus to
cells and that L* protein rather has effect(s) on the
amount of viral genomic RNA (Obuchi et al., 2000; Takata
et al., 1998). Therefore, the association of L* protein with
microtubules may clarify the reason that the synthesis of
L* protein affects TMEV growth in specific cell types as
well as its role in DA-induced disease.
MATERIALS AND METHODS
Cells and viruses
BHK-21 cells were maintained in Eagle’s minimum
essential medium (MEM) supplemented with 5% calf
serum and 60 mg of kanamycin/ml. J774-1 cells were
described in the text, the whole L* coding region and three truncated
of the L* coding region were amplified by polymerase chain reaction.
MV-Tag L*N, pCMV-Tag L*M, and pCMV-Tag L*C, respectively. BHK-21
re as described in the text. Cells were stained with anti-FLAG and
g, the cells were further incubated with Cy3-conjugated anti-b-tubulin
L*/b-tubulin, pCMV-Tag L*N/b-tubulin, pCMV-Tag L*M/b-tubulin, and
as demonstrated. Although almost the same feature was observed in
iverged from that of b-tubulin. (a) the merging image of pCMV-Tag
MV-Tag L*C/b-tubulin.ns. As
5–156
g L*, pC
rocedu
stainin
V-Tag
bulin waintained in RPMI 1640 medium supplemented with
0% fetal bovine serum. The seed virus of the DA strain
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100 OBUCHI ET AL.was propagated in BHK-21 cells. DAL*-1 virus synthesiz-
ing no L* protein (Kong and Roos, 1991) was also prop-
agated in BHK-21 cells. These viruses were stored at
280°C until use. Virus purification was performed ac-
cording to the previous report (Roos et al., 1982) with a
light modification. Briefly, at 16 h after infection, cells
ere disrupted by one cycle of freezing and thawing,
ysed with 1% Nonidet P-40, clarified at 12,000 g at 4°C
or 10 min, and adjusted to 1% SDS for 30 min at room
emperature. Virus was then pelleted through 3 ml of 30%
ucrose in an SW28 rotor at 76,000 g at 20°C for 17 h.
he pellet was suspended in NTE buffer [10 mM NaCl, 10
M Tris–HCl (pH 7.4), 2 mM EDTA] containing 1% Brij 58
nd banded in CsCl in an SW50.1 rotor at 155,000 g at
°C for 20 h. Fractions containing virus were collected by
uncturing the tube bottom, diluted with 20 mM Tris–HCl,
H 7.5. The virus was pelleted in a 50 Ti rotor at 155,000
at 4°C for 2 h, suspended in 20 mM Tris–HCl, pH 7.5.
ntibodies
Peptides corresponding to the computer predicted
hree antigenic sites were synthesized; amino acid
esidues 70–88 (NPRETPLHLTRVTPSPQVT), 118–136
PKTTDNCRTSWAALQMLLL), and 139–156 (HLSSWIK-
QRRWRISLTE). Each was coupled to keyhole limpet
emocyanin (by Sawady Technology Co., Inc., Tokyo,
apan) and purified 90.3–92.4% by high-pressure liquid
hromatography. Rabbits were immunized separately
ith 0.2 mg of each peptide in complete Freund’s adju-
ant, followed by three booster injections of 0.2 mg each
n incomplete Freund’s adjuvant at 2-week intervals. DA-
eutralizing monoclonal antibody, DAmAb2 (Nitayaphan
t al., 1985), was kindly supplied by Dr. Raymond P. Roos,
niversity of Chicago Medical Center. For detection of
icrotubules, Cy3-conjugated anti-b-tubulin monoclonal
ntibody (clone TUB 2.1) was used for immunofluores-
ence studies, and anti-a-tubulin monoclonal antibody
(clone DM1A) was used for Western blotting; these an-
tibodies were obtained from Sigma (St. Louis, MO). For
detection of vimentin, Cy3-conjugated anti-vimentin
monoclonal antibody (clone V9, Sigma) was also used.
For detection of the in vitro expression of the whole L*
protein or the truncated L* protein, anti-FLAG polyclonal
rabbit antibody (BioReagents, Inc., Golden, CO) was
used.
Radiolabeling of infected cells
Radiolabeling of infected cells was performed as pre-
viously described (Obuchi et al., 2000). Briefly, BHK-21
cells were infected with DA strain at a multiplicity of
infection (m.o.i.) of 10 PFU per cell. After adsorption at
37°C for 1 h, the cells were incubated in Eagle’s MEM
containing 2% calf serum and actinomycin D (2.4 mg/ml).t 0, 2, 4, 6, 8, and 10 h p.i., the medium was replaced
ith methionine-free Eagle’s MEM containing 1% calfserum and then 50 mCi of L-[35S]methionine/cysteine was
dded. After 2 h, labeled cells were scraped, washed
wice with cold phosphate-buffered saline (PBS), and
issolved in the sample buffer [50 mM Tris–HCl (pH 6.8),
% SDS, 0.005% bromophenol blue, 10% glycerol, and
% b-mercaptoethanol]. Radiolabeled proteins were
separated by SDS–15% PAGE and analyzed by auto-
radiography.
For pulse–chase experiments, cells were labeled for
10 or 60 min as described above, subsequently washed
three times in Eagle’s MEM supplemented with 0.15 mg
of methionine/ml and 0.31 mg of cystein/ml (10-fold
greater than the normal concentration), and incubated for
1, 3, and 9 h at 37°C in Eagle’s MEM supplemented with
the above-described concentrations of methionine and
cysteine.
Western blotting
Western blotting was performed as previously de-
scribed (Obuchi et al., 2000). Unlabeled proteins were
separated by SDS–15% PAGE and transferred to a nitro-
cellulose membrane (Amersham Pharmacia Biotech Ltd.,
Bickinghamshire, United Kingdom). Polyclonal rabbit or
monoclonal mouse antibody was used as the first anti-
body. Horseradish peroxidase-conjugated anti-rabbit IgG
or anti-mouse IgG (Amersham Pharmacia Biotech Ltd.)
was used as the second antibody and detected by en-
hanced chemiluminescence (Amersham Pharmacia Bio-
tech Ltd.).
Preparation of microtubules
Microtubules were prepared as described (Ookata et
al., 1993) with a minor modification. Infected cells were
homogenized in 2 vol of 0.1 M 2-(N-morpholino)ethane-
sulfonic acid, pH 6.8, 2 mM EGTA, 1 mM MgCl2 contain-
ng 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl
luoride, 5 mg/ml of leupeptin, and 5 mg/ml of pepstatin A
at 4°C and then centrifuged in a 50 Ti rotor at 100,000 g
for 30 min at 4°C. Paclitaxel and GTP were added to the
supernatant to final concentrations of 20 mM and 0.5
mM, respectively. The solution was warmed to 37°C for
10 min and then chilled on ice for 10 min. Polymerized
microtubules were collected by centrifugation in a 50 Ti
rotor at 30,000 g for 30 min at 4°C through a cushion of
0.1 M 2-(N-morpholino)ethanesulfonic acid, pH 6.8, 2 mM
EGTA, 1 mM MgCl2, 20 mM paclitaxel, and 0.5 mM GTP
containing 10% sucrose. The pellet was dissolved in the
sample buffer for SDS–PAGE.
Immunofluorescent staining
BHK-21 cells were grown on chamber slides (Nalge
Nunc Int., Naperville, IL), and infected with the DA strain
at an m.o.i. of 10 PFU per cell. Cells were washed with
PBS, fixed in 4% paraformaldehyde for 10 min at room
temperature, and permeabilized with 0.2% Triton X-100 in
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101ASSOCIATION OF L* PROTEIN OF TMEV WITH MICROTUBULESPBS for 2 min. After washing with PBS, aL* antibody was
added and incubated for 60 min at room temperature.
The cells were then washed with PBS and incubated for
another 60 min at room temperature with FITC-conju-
gated goat anti-rabbit IgG (H 1 L) (Vector Laboratories,
Inc., Burlingame, CA). For L*/tubulin double staining,
cells were incubated after the staining of L* for an addi-
tional 60 min with Cy3-conjugated anti-b-tubulin mono-
lonal antibody. After washing with PBS, the chamber
lides were examined by fluorescence microscopy. For
ctin and vimentin staining, tetramethylrhodamine iso-
hiocyanate-conjugated phalloidin (Sigma), which specif-
cally binds to actin, and Cy3-conjugated anti-vimentin
onoclonal antibody were used, respectively. For tran-
ient in vitro expression of L* protein, anti-FLAG antibody
nstead of aL* antibody was used.
ransient expression of L* protein in BHK-21 cells
pCMV-Tag2 (Stratagene, La Jolla, CA) was used for
xpression, which contains a sequence for the FLAG
pitope tag at the amino terminus. Three truncated frag-
ents, designated N, M, and C, which correspond to
mino acid residues 1–52, 53–104, and 105–156 of the L*
oding region, were amplified by polymerase chain re-
ction (PCR) using pDAFL3, a full-length infectious cDNA
lone generated from the DA strain (Roos et al., 1989), as
template. The fragment corresponding to the whole L*
oding region was also amplified by PCR. The primers
or PCR were synthesized according to the published
equence (Ohara et al., 1988). Those have a BamHI or
indIII site at the end and an anchor site for the corre-
ponding fragment at the other end. The amplified whole
*, N, M, and C fragments were cloned into BamHI and
HindIII sites in pCMV-Tag2. The constructs were desig-
nated pCMV-Tag L*, pCMV-Tag L*N, pCMV-Tag L*M, and
pCMV-Tag L*C, respectively. The sequences of con-
structs were confirmed by an ABI PRISM 310 Genetic
Analyzer (Perkin–Elmer, Norwalk, CT).
BHK-21 cells were transfected by the DEAE–dextran
procedure (Sambrook and Russell, 2001) with some mod-
ifications. Briefly, cells were plated to 35-mm-diameter
plastic culture dishes at a density of 1 3 105 cells per
ish. After 20 h, the medium was replaced with 1 ml of
EAE–dextran/chloroquine solution [0.4 mg/ml DEAE
extran and 0.1 mM chloroquine diphosphate in Iso-
ove’s modified Dulbecco’s medium supplemented with
0% NuSerum (Becton–Dickinson Labware, Bedford,
A)] containing 1 mg of plasmid DNA. The dishes were
incubated at 37°C in a humidified incubator with an
atmosphere of 5% CO2. After 2.5 h, the medium was
eplaced with Eagle’s MEM containing 2% calf serum
nd 60 mg of kanamycin/ml. After 24 h, the cells were
scraped and replated on chamber slides. The cells were
fixed as described above for immunofluorescent staining
96 h after transfection.ACKNOWLEDGMENTS
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